CIK 0001612940 · Accelerated filer
ProQR Therapeutics N.V.
Sign in to watch- Ticker
- PRQR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- other
- Phone
- 31 88 166 7000
- Business address
- ZERNIKEDREEF 9, LEIDEN, Netherlands
- Former names
- ProQR Therapeutics B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | de Boer Daniel Anton Chief Executive Officer | Purchase | +200,000 | $1.77 | $354K | 500,000 |
| 2026-07-17 | Filius Bart Director | Purchase | +150,000 | $1.72 | $258K | 300,000 |
| 2026-07-09 | de Boer Daniel Anton Chief Executive Officer | Purchase | +150,000 | $1.74 | $261K | 300,000 |
| 2026-07-07 | de Boer Daniel Anton Chief Executive Officer | Purchase | +150,000 | $1.59 | $239K | 150,000 |
| 2026-06-26 | Filius Bart Director | Purchase | +150,000 | $1.54 | $231K | 150,000 |
| 2026-06-02 | Hinsch Gylvin Lykke Director | Grant or award · Share Option (Right to Buy) | +14,595 | 14,595 | ||
| 2026-06-02 | Hinsch Gylvin Lykke Director | Grant or award · Share Option (Right to Buy) | +14,495 | 14,495 |
Page 1 of 1 · 7 trades